Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Fly Intel: Top five analyst initiations » 10:10
07/15/20
07/15
10:10
07/15/20
10:10
LVGO

Livongo Health

$107.30 /

+6.12 (+6.05%)

, TALO

Talos Energy

$8.39 /

+0.54 (+6.88%)

, WDC

Western Digital

$44.02 /

+1.97 (+4.68%)

, STX

Seagate

$48.31 /

+0.94 (+1.98%)

, SAM

Boston Beer

$624.00 /

+1.73 (+0.28%)

, PROG

Progenity

$9.54 /

+0.15 (+1.60%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Livongo Health (LVGO) initiated with an Outperform at Credit Suisse. 2. Talos Energy (TALO) initiated with a Buy at Stifel. 3. Western Digital (WDC) was initiated with an Outperform at Bernstein while Seagate (STX) was initiated with a Market Perform. 4. Boston Beer (SAM) initiated with an Outperform at Evercore ISI. 5. Progenity (PROG) initiated with an Outperform at Baird and Raymond James and an Overweight at Wells Fargo and Piper Sandler. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
WDC Western Digital
$44.02 /

+1.97 (+4.68%)

TALO Talos Energy
$8.39 /

+0.54 (+6.88%)

STX Seagate
$48.31 /

+0.94 (+1.98%)

SAM Boston Beer
$624.00 /

+1.73 (+0.28%)

LVGO Livongo Health
$107.30 /

+6.12 (+6.05%)

LVGO Livongo Health
$107.30 /

+6.12 (+6.05%)

07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
07/14/20 Citi
Livongo Health initiated with a Buy at Citi
07/09/20 Canaccord
Livongo Health price target raised to $110 from $69 at Canaccord
TALO Talos Energy
$8.39 /

+0.54 (+6.88%)

07/14/20 Stifel
Talos Energy initiated with a Buy at Stifel
06/25/20 MKM Partners
Talos Energy initiated with a Buy at MKM Partners
06/24/20 MKM Partners
Talos Energy initiated with a Buy at MKM Partners
06/04/20
Fly Intel: Top five analyst initiations
WDC Western Digital
$44.02 /

+1.97 (+4.68%)

07/14/20 Bernstein
Seagate initiated with a Market Perform at Bernstein
07/14/20 Bernstein
Western Digital initiated with an Outperform at Bernstein
07/14/20 Bernstein
Western Digital initiated with an Outperform at Bernstein
06/30/20 Benchmark
Micron report and guidance 'bode well' for Western Digital, says Benchmark
STX Seagate
$48.31 /

+0.94 (+1.98%)

06/19/20 Benchmark
Benchmark says Samsung's NAND chip issues likely positive for HDD makers
06/08/20 Rosenblatt
Rosenblatt starts Western Digital at Neutral, sees technology lagging Seagate
SAM Boston Beer
$624.00 /

+1.73 (+0.28%)

07/15/20 Deutsche Bank
Boston Beer price target raised to $540 from $481 at Deutsche Bank
07/14/20 Evercore ISI
Boston Beer initiated with an Outperform at Evercore ISI
06/10/20 Guggenheim
Boston Beer price target raised to $609 from $549 at Guggenheim
06/08/20 RBC Capital
Boston Beer price target raised to $575 from $427 at RBC Capital
PROG Progenity
$9.54 /

+0.15 (+1.60%)

07/14/20 Baird
Progenity initiated with an Outperform at Baird
07/14/20 Piper Sandler
Progenity initiated with an Overweight at Piper Sandler
07/14/20 Raymond James
Progenity initiated with an Outperform at Raymond James
07/14/20 Raymond James
Progenity initiated with an Outperform at Raymond James
WDC Western Digital
$44.02 /

+1.97 (+4.68%)

TALO Talos Energy
$8.39 /

+0.54 (+6.88%)

STX Seagate
$48.31 /

+0.94 (+1.98%)

SAM Boston Beer
$624.00 /

+1.73 (+0.28%)

LVGO Livongo Health
$107.30 /

+6.12 (+6.05%)

  • 19
    Jun
  • 12
    Dec
  • 25
    Jul
WDC Western Digital
$44.02 /

+1.97 (+4.68%)

STX Seagate
$48.31 /

+0.94 (+1.98%)

SAM Boston Beer
$624.00 /

+1.73 (+0.28%)

LVGO Livongo Health
$107.30 /

+6.12 (+6.05%)

WDC Western Digital
$44.02 /

+1.97 (+4.68%)

TALO Talos Energy
$8.39 /

+0.54 (+6.88%)

STX Seagate
$48.31 /

+0.94 (+1.98%)

SAM Boston Beer
$624.00 /

+1.73 (+0.28%)

PROG Progenity
$9.54 /

+0.15 (+1.60%)

LVGO Livongo Health
$107.30 /

+6.12 (+6.05%)

WDC Western Digital
$44.02 /

+1.97 (+4.68%)

STX Seagate
$48.31 /

+0.94 (+1.98%)

LVGO Livongo Health
$107.30 /

+6.12 (+6.05%)

Tuesday
On The Fly
Fly Intel: After-Hours Movers » 19:00
07/14/20
07/14
19:00
07/14/20
19:00
LCII

LCI Industries

$112.96 /

+3.12 (+2.84%)

, MRNA

Moderna

$75.04 /

+3.32 (+4.63%)

, LVGO

Livongo Health

$101.18 /

+3.81 (+3.91%)

, PVH

PVH Corp.

$46.52 /

+1.14 (+2.51%)

, VNOM

Viper Energy

$10.05 /

+0.48 (+5.02%)

, TALO

Talos Energy

$7.85 /

+0.28 (+3.70%)

, GSK

GlaxoSmithKline

$40.70 /

+0.635 (+1.58%)

, KRUS

Kura Sushi

$11.09 /

-1.34 (-10.78%)

, ZYXI

Zynex

$26.20 /

+0.115 (+0.44%)

, ADPT

Adaptive Biotechnologies

$43.18 /

-0.98 (-2.22%)

Open Full Text

ShowHide Related Items >><<
ZYXI Zynex
$26.20 /

+0.115 (+0.44%)

VNOM Viper Energy
$10.05 /

+0.48 (+5.02%)

TALO Talos Energy
$7.85 /

+0.28 (+3.70%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

MRNA Moderna
$75.04 /

+3.32 (+4.63%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

LCII LCI Industries
$112.96 /

+3.12 (+2.84%)

KRUS Kura Sushi
$11.09 /

-1.34 (-10.78%)

GSK GlaxoSmithKline
$40.70 /

+0.635 (+1.58%)

ADPT Adaptive Biotechnologies
$43.18 /

-0.98 (-2.22%)

LCII LCI Industries
$112.96 /

+3.12 (+2.84%)

07/06/20 Citi
LCI Industries initiated with a Neutral at Citi
05/07/20 Sidoti
LCI Industries downgraded to Neutral from Buy at Sidoti
04/17/20 Wolfe Research
LCI Industries initiated with an Outperform at Wolfe Research
03/17/20 Sidoti
LCI Industries upgraded to Buy from Neutral at Sidoti
MRNA Moderna
$75.04 /

+3.32 (+4.63%)

07/14/20 Piper Sandler
Moderna COVID vaccine trial on track for July start, says Piper Sandler
07/13/20 Brookline
Moderna initiated with a Buy at Brookline
07/13/20 Jefferies
Jefferies starts Moderna with Buy rating, $90 price target
07/08/20 Piper Sandler
Piper reiterates $100 target on Moderna after Phase II study enrolled
LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
07/14/20 Citi
Livongo Health initiated with a Buy at Citi
07/09/20 Canaccord
Livongo Health price target raised to $110 from $69 at Canaccord
PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

06/15/20 DA Davidson
PVH Corp. price target raised to $60 from $41 at DA Davidson
06/15/20 Barclays
PVH Corp. price target lowered to $51 from $67 at Barclays
06/15/20 RBC Capital
PVH Corp. price target raised to $48 from $30 at RBC Capital
06/12/20 Deutsche Bank
PVH Corp. price target lowered to $42 from $44 at Deutsche Bank
VNOM Viper Energy
$10.05 /

+0.48 (+5.02%)

06/22/20 Goldman Sachs
Diamondback Energy downgraded to Neutral from Buy at Goldman Sachs
06/12/20 KeyBanc
Viper Energy price target raised to $13 from $10 at KeyBanc
03/30/20 Citi
Viper Energy price target lowered to $12 from $35 at Citi
03/27/20 Imperial Capital
Viper Energy price target lowered to $10 from $30 at Imperial Capital
TALO Talos Energy
$7.85 /

+0.28 (+3.70%)

07/14/20 Stifel
Talos Energy initiated with a Buy at Stifel
06/25/20 MKM Partners
Talos Energy initiated with a Buy at MKM Partners
06/24/20 MKM Partners
Talos Energy initiated with a Buy at MKM Partners
06/04/20
Fly Intel: Top five analyst initiations
GSK GlaxoSmithKline
$40.70 /

+0.635 (+1.58%)

07/13/20 UBS
UBS reiterates Buy on GSK as FDA belantamab docs are out
07/13/20 JPMorgan
Ideaya upgraded to Overweight on recent pullback at JPMorgan
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
KRUS Kura Sushi
$11.09 /

-1.34 (-10.78%)

07/10/20
Fly Intel: Top five analyst downgrades
07/10/20 Craig-Hallum
Kura Sushi downgraded to Hold from Buy at Craig-Hallum
06/16/20 Roth Capital
Kura Sushi initiated with a Buy at Roth Capital
04/27/20
Fly Intel: Top five analyst initiations
ZYXI Zynex
$26.20 /

+0.115 (+0.44%)

07/13/20 B. Riley FBR
Zynex downgraded to Neutral on valuation at B. Riley FBR
07/13/20 B. Riley FBR
Zynex downgraded to Neutral from Buy at B. Riley FBR
07/10/20 H.C. Wainwright
Zynex price target raised to $30 from $20 at H.C. Wainwright
06/16/20 Northland
Zynex downgraded to Market Perform from Outperform at Northland
ADPT Adaptive Biotechnologies
$43.18 /

-0.98 (-2.22%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
ZYXI Zynex
$26.20 /

+0.115 (+0.44%)

VNOM Viper Energy
$10.05 /

+0.48 (+5.02%)

TALO Talos Energy
$7.85 /

+0.28 (+3.70%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

MRNA Moderna
$75.04 /

+3.32 (+4.63%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

LCII LCI Industries
$112.96 /

+3.12 (+2.84%)

KRUS Kura Sushi
$11.09 /

-1.34 (-10.78%)

GSK GlaxoSmithKline
$40.70 /

+0.635 (+1.58%)

ADPT Adaptive Biotechnologies
$43.18 /

-0.98 (-2.22%)

  • 16
    Jul
  • 15
    Jul
  • 19
    May
  • 12
    Feb
  • 24
    Jan
  • 12
    Dec
  • 01
    Aug
  • 25
    Jul
MRNA Moderna
$75.04 /

+3.32 (+4.63%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

GSK GlaxoSmithKline
$40.70 /

+0.635 (+1.58%)

VNOM Viper Energy
$10.05 /

+0.48 (+5.02%)

TALO Talos Energy
$7.85 /

+0.28 (+3.70%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

MRNA Moderna
$75.04 /

+3.32 (+4.63%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

KRUS Kura Sushi
$11.09 /

-1.34 (-10.78%)

GSK GlaxoSmithKline
$40.70 /

+0.635 (+1.58%)

ADPT Adaptive Biotechnologies
$43.18 /

-0.98 (-2.22%)

VNOM Viper Energy
$10.05 /

+0.48 (+5.02%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

MRNA Moderna
$75.04 /

+3.32 (+4.63%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

GSK GlaxoSmithKline
$40.70 /

+0.635 (+1.58%)

Hot Stocks
Livongo Health Founder: We work hand in hand with Teladoc » 18:22
07/14/20
07/14
18:22
07/14/20
18:22
LVGO

Livongo Health

$101.18 /

+3.81 (+3.91%)

, TDOC

Teladoc

$208.96 /

-9.53 (-4.36%)

In an interview on…

In an interview on CNBC's Mad Money, Glen Tullman said he expects many more companies to move to Livongo in the near future. Employers are doubling down on Livongo to keep employees productive and healthy, according to Tullman. Telehealth is one-on-one, but Livongo takes it to the next level, he noted.

ShowHide Related Items >><<
TDOC Teladoc
$208.96 /

-9.53 (-4.36%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
07/14/20 Citi
Livongo Health initiated with a Buy at Citi
07/09/20 Canaccord
Livongo Health price target raised to $110 from $69 at Canaccord
TDOC Teladoc
$208.96 /

-9.53 (-4.36%)

07/14/20 Citi
Teladoc initiated with a Buy at Citi
07/13/20 Argus
Teladoc initiated with a Buy at Argus
07/13/20 Argus
Teladoc initiated with a Buy at Argus
07/06/20 Stephens
Teladoc initiated with an Overweight at Stephens
TDOC Teladoc
$208.96 /

-9.53 (-4.36%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

  • 12
    Dec
  • 25
    Jul
TDOC Teladoc
$208.96 /

-9.53 (-4.36%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

TDOC Teladoc
$208.96 /

-9.53 (-4.36%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

TDOC Teladoc
$208.96 /

-9.53 (-4.36%)

LVGO Livongo Health
$101.18 /

+3.81 (+3.91%)

Initiation
Livongo Health initiated with an Outperform at Credit Suisse » 16:09
07/14/20
07/14
16:09
07/14/20
16:09
LVGO

Livongo Health

$101.27 /

+3.9 (+4.01%)

Credit Suisse analyst…

Credit Suisse analyst Jailendra Singh initiated coverage of Livongo Health with an Outperform rating and $132 price target. The company operates in a "highly underpenetrated and growing" chronic care market, Singh tells investors in a research note. The analyst believes Livongo is "barely scratching the surface" in a market which the company sizes at $46.7B. This estimate is conservative as Livongo uses chronic disease prevalence and population estimates using 2015 data, which have moved exponentially higher today, says Singh. The analyst also sees "several other areas" of chronic care management that are largely underpenetrated where Livongo has yet to enter.

ShowHide Related Items >><<
LVGO Livongo Health
$101.27 /

+3.9 (+4.01%)

LVGO Livongo Health
$101.27 /

+3.9 (+4.01%)

07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
07/14/20 Citi
Livongo Health initiated with a Buy at Citi
07/09/20 Canaccord
Livongo Health price target raised to $110 from $69 at Canaccord
07/08/20 RBC Capital
Livongo Health price target raised to $120 from $53 at RBC Capital
LVGO Livongo Health
$101.27 /

+3.9 (+4.01%)

  • 12
    Dec
  • 25
    Jul
LVGO Livongo Health
$101.27 /

+3.9 (+4.01%)

LVGO Livongo Health
$101.27 /

+3.9 (+4.01%)

LVGO Livongo Health
$101.27 /

+3.9 (+4.01%)

On The Fly
UnitedHealth's new diabetes service not seen impacting Livongo near-term » 12:12
07/14/20
07/14
12:12
07/14/20
12:12
LVGO

Livongo Health

$98.54 /

+1.17 (+1.20%)

, UNH

UnitedHealth

$304.48 /

+4.47 (+1.49%)

, TDOC

Teladoc

$209.40 /

-9.09 (-4.16%)

, HCAT

Health Catalyst

$32.96 /

+0.67 (+2.07%)

, CHNG

Change Healthcare

$10.55 /

+0.53 (+5.29%)

Shares of Livongo Health…

Open Full Text

ShowHide Related Items >><<
UNH UnitedHealth
$304.48 /

+4.47 (+1.49%)

TDOC Teladoc
$209.40 /

-9.09 (-4.16%)

LVGO Livongo Health
$98.54 /

+1.17 (+1.20%)

HCAT Health Catalyst
$32.96 /

+0.67 (+2.07%)

CHNG Change Healthcare
$10.55 /

+0.53 (+5.29%)

LVGO Livongo Health
$98.54 /

+1.17 (+1.20%)

07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
07/14/20 Citi
Livongo Health initiated with a Buy at Citi
07/09/20 Canaccord
Livongo Health price target raised to $110 from $69 at Canaccord
07/08/20 RBC Capital
Livongo Health price target raised to $120 from $53 at RBC Capital
UNH UnitedHealth
$304.48 /

+4.47 (+1.49%)

07/07/20 Cantor Fitzgerald
UnitedHealth likely to reiterate 2020 outlook, says Cantor Fitzgerald
07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
07/01/20 SVB Leerink
UnitedHealth reinstated with an Outperform at SVB Leerink
TDOC Teladoc
$209.40 /

-9.09 (-4.16%)

07/14/20 Citi
Teladoc initiated with a Buy at Citi
07/13/20 Argus
Teladoc initiated with a Buy at Argus
07/13/20 Argus
Teladoc initiated with a Buy at Argus
07/06/20 Stephens
Teladoc initiated with an Overweight at Stephens
HCAT Health Catalyst
$32.96 /

+0.67 (+2.07%)

07/14/20 Citi
Health Catalyst initiated with a Buy at Citi
07/10/20 SVB Leerink
Health Catalyst price target raised to $40 from $32 at SVB Leerink
06/18/20 Stifel
Health Catalyst initiated with a Buy at Stifel
06/15/20 Evercore ISI
Health Catalyst assumed with an Outperform at Evercore ISI
CHNG Change Healthcare
$10.55 /

+0.53 (+5.29%)

07/14/20 Citi
Change Healthcare initiated with a Buy at Citi
06/10/20 KeyBanc
Inovalon displaces Change Healthcare in Priority Health deal, says KeyBanc
06/09/20 Piper Sandler
Piper Sandler says buy Change Healthcare, sell Inovalon
04/13/20 SVB Leerink
Change Healthcare initiated with an Outperform at SVB Leerink
UNH UnitedHealth
$304.48 /

+4.47 (+1.49%)

TDOC Teladoc
$209.40 /

-9.09 (-4.16%)

LVGO Livongo Health
$98.54 /

+1.17 (+1.20%)

HCAT Health Catalyst
$32.96 /

+0.67 (+2.07%)

CHNG Change Healthcare
$10.55 /

+0.53 (+5.29%)

  • 12
    Dec
  • 25
    Jul
  • 25
    Jul
UNH UnitedHealth
$304.48 /

+4.47 (+1.49%)

TDOC Teladoc
$209.40 /

-9.09 (-4.16%)

LVGO Livongo Health
$98.54 /

+1.17 (+1.20%)

CHNG Change Healthcare
$10.55 /

+0.53 (+5.29%)

UNH UnitedHealth
$304.48 /

+4.47 (+1.49%)

TDOC Teladoc
$209.40 /

-9.09 (-4.16%)

LVGO Livongo Health
$98.54 /

+1.17 (+1.20%)

HCAT Health Catalyst
$32.96 /

+0.67 (+2.07%)

CHNG Change Healthcare
$10.55 /

+0.53 (+5.29%)

UNH UnitedHealth
$304.48 /

+4.47 (+1.49%)

TDOC Teladoc
$209.40 /

-9.09 (-4.16%)

LVGO Livongo Health
$98.54 /

+1.17 (+1.20%)

CHNG Change Healthcare
$10.55 /

+0.53 (+5.29%)

Recommendations
UnitedHealth competition won't impact Livongo near term, says KeyBanc » 08:32
07/14/20
07/14
08:32
07/14/20
08:32
LVGO

Livongo Health

$97.37 /

-8.21 (-7.78%)

, UNH

UnitedHealth

$300.01 /

+8.705 (+2.99%)

KeyBanc analyst Donald…

KeyBanc analyst Donald Hooker reiterates an Overweight rating on Livongo Health (LVGO) with a $105 price target after UnitedHealth (UNH) yesterday launched a competitive digital diabetes service. The stock closed yesterday down 8%, or $8.30, to $97.38. The analyst does not expect any impact to Livongo's near-term results, noting that UnitedHealth is not a channel partner. Also, it appears that UnitedHealth's new diabetes service will be "channel-limited" to its own client base, Hooker tells investors in a research note titled "Imitation Is the Greatest Form of Flattery." Further, Livongo to date has demonstrated high client retention of 94%, adds the analyst. In a "bull-case" scenario, he sees UnitedHealth's entry into the digital diabetes space as an accelerant for Livongo. The move could put competitive pressure on regional Blues and other health plans to more aggressively feature their own digital diabetes solution, says Hooker. In a "bear-case" scenario, UnitedHealth's Level2 launch could make it more difficult for Livongo to prospect within UnitedHealth's small- and mid-sized employer client base, notes the analyst.

ShowHide Related Items >><<
UNH UnitedHealth
$300.01 /

+8.705 (+2.99%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

07/14/20 Citi
Livongo Health initiated with a Buy at Citi
07/09/20 Canaccord
Livongo Health price target raised to $110 from $69 at Canaccord
07/08/20 RBC Capital
Livongo Health price target raised to $120 from $53 at RBC Capital
07/08/20 Needham
Livongo Health price target raised to $120 from $70 at Needham
UNH UnitedHealth
$300.01 /

+8.705 (+2.99%)

07/07/20 Cantor Fitzgerald
UnitedHealth likely to reiterate 2020 outlook, says Cantor Fitzgerald
07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
07/01/20 SVB Leerink
UnitedHealth reinstated with an Outperform at SVB Leerink
06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
UNH UnitedHealth
$300.01 /

+8.705 (+2.99%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

  • 12
    Dec
  • 25
    Jul
UNH UnitedHealth
$300.01 /

+8.705 (+2.99%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

UNH UnitedHealth
$300.01 /

+8.705 (+2.99%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

UNH UnitedHealth
$300.01 /

+8.705 (+2.99%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

Initiation
Livongo Health initiated with a Buy at Citi » 07:18
07/14/20
07/14
07:18
07/14/20
07:18
LVGO

Livongo Health

$97.37 /

-8.21 (-7.78%)

Citi analyst Daniel…

Citi analyst Daniel Grosslight initiated coverage of Livongo Health (LVGO) with a Buy rating and $125 price target. The analyst rolled out coverage of the healthcare technology sector with a positive bias. A new era of healthcare technology investing has emerged, and the healthcare ecosystem is on verge of its "Netflix moment," Grosslight tells investors in a research note. The analyst favors companies with interoperable platforms, omni-channel distribution and strong relationships with patient aggregators. His top picks for investors looking for "SMID-cap growth and disruption" are Teladoc Health (TDOC) and Health Catalyst (HCAT). For investors looking for value, Grosslight's top pick is Change Healthcare (CHNG).

ShowHide Related Items >><<
LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

07/09/20 Canaccord
Livongo Health price target raised to $110 from $69 at Canaccord
07/08/20 RBC Capital
Livongo Health price target raised to $120 from $53 at RBC Capital
07/08/20 Needham
Livongo Health price target raised to $120 from $70 at Needham
07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

  • 12
    Dec
  • 25
    Jul
LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

LVGO Livongo Health
$97.37 /

-8.21 (-7.78%)

Over a week ago
Recommendations
Livongo Health price target raised to $110 from $69 at Canaccord » 07:36
07/09/20
07/09
07:36
07/09/20
07:36
LVGO

Livongo Health

$96.81 /

+3.05 (+3.25%)

Canaccord analyst Richard…

Canaccord analyst Richard Close raised the firm's price target on Livongo Health to $110 from $69 and keeps a Buy rating on the shares. The price target increase reflects the positive Q2 preannouncement which suggests the company continues to outperform and execute on its business plan with strong customer launches year-to-date, improved enrollment and retention, and impressive upside to revenues versus guidance.

ShowHide Related Items >><<
LVGO Livongo Health
$96.81 /

+3.05 (+3.25%)

LVGO Livongo Health
$96.81 /

+3.05 (+3.25%)

07/08/20 RBC Capital
Livongo Health price target raised to $120 from $53 at RBC Capital
07/08/20 Needham
Livongo Health price target raised to $120 from $70 at Needham
07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
07/07/20 Morgan Stanley
Livongo Health price target raised to $89 from $62 at Morgan Stanley
LVGO Livongo Health
$96.81 /

+3.05 (+3.25%)

  • 12
    Dec
  • 25
    Jul
LVGO Livongo Health
$96.81 /

+3.05 (+3.25%)

LVGO Livongo Health
$96.81 /

+3.05 (+3.25%)

LVGO Livongo Health
$96.81 /

+3.05 (+3.25%)

Recommendations
Livongo Health price target raised to $120 from $53 at RBC Capital » 09:11
07/08/20
07/08
09:11
07/08/20
09:11
LVGO

Livongo Health

$93.76 /

+16.19 (+20.87%)

RBC Capital analyst Sean…

RBC Capital analyst Sean Dodge raised the firm's price target on Livongo Health to $120 from $53 and keeps an Outperform rating on the shares. The analyst is citing the company's "significant" total addressable market and his expectation for continued revenue growth at a "blistering" pace of 60%-65% over the next two years. Dodge adds that Livongo's "AI+AI engine/service delivery" is also "increasingly scalable."

ShowHide Related Items >><<
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

07/08/20 Needham
Livongo Health price target raised to $120 from $70 at Needham
07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
07/07/20 Morgan Stanley
Livongo Health price target raised to $89 from $62 at Morgan Stanley
07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

  • 12
    Dec
  • 25
    Jul
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

Recommendations
Livongo Health price target raised to $120 from $70 at Needham » 07:30
07/08/20
07/08
07:30
07/08/20
07:30
LVGO

Livongo Health

$93.76 /

+16.19 (+20.87%)

Needham analyst Scott…

Needham analyst Scott Berg raised the firm's price target on Livongo Health to $120 from $70 and keeps a Buy rating on the shares after the company raised its Q2 revenue guidance yesterday. The outlook was driven by a combination of faster-than-expected new member additions and lower-than-modeled churn, the analyst tells investors in a research note, stating that churn had been modeled "conservatively" due to the COVID-19 uncertainty. Berg adds that Livongo is in a hyper-growth phase and that its stock "should be valued above the upper end of the historical peer-group range."

ShowHide Related Items >><<
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
07/07/20 Morgan Stanley
Livongo Health price target raised to $89 from $62 at Morgan Stanley
07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
07/06/20 Stephens
Livongo initiated with Overweight, named Best Idea at Stephens
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

  • 12
    Dec
  • 25
    Jul
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.